3 | SEC Filings Hub

Filing metadata

Accession number: 0001209191-18-025212
Form type: Form 3
Filer: Outlook Therapeutics, Inc.
CIK: CIK 1649989
Filed: Apr 17, 2018
Reporting period: Apr 13, 2018
Description: Initial ownership

Documents

0001209191-18-025212-index.htm

Complete submission

0001209191-18-025212.txt

directory listing

Filed by

Outlook Therapeutics, Inc.